A federal appeals court has ordered the FDA to make an older version of the morning after contraceptive, which comprises two pills, available to women, irrespective of age. However, the one-pill version will still be subject to age limits. The FDA had challenged an order to eliminate age and other restrictions on who may buy morning-after, or "Plan B" pills. The appeals court will hear the overall case - on access to contraceptives - on an expedited basis. Companies affected include Teva (TEVA), Perrigo (PRGO) and Actavis (ACT).